Related Experiment Video
Updated: Oct 25, 2025
10:49
Visualizing Efficacy of Pesticides Against Disease Vector Mosquitoes in the Field
Published on: March 16, 2019
8.7K
Beyond Efficacy and Effectiveness: Clinical Efficiency Is Necessary for Dissemination
Alessandro S De Nadai1, Joseph L Etherton2
1Texas State University, San Marcos, TX adenadai@txstate.edu.
Journal of Cognitive Psychotherapy
|August 7, 2021
Summary
To improve mental health care access, understanding clinical efficiency is crucial. A new metric, the incremental time efficiency ratio (ITER), quantifies resource use and therapeutic gains, aiding gatekeeper referrals.
Area of Science:
- Health Services Research
- Mental Health Dissemination
- Health Economics
Background:
- Healthcare gatekeepers (insurers, systems) control patient access to evidence-based mental health care.
- Referral decisions by gatekeepers require data on resources used to achieve therapeutic outcomes.
- Lack of resource-outcome data creates a bottleneck in disseminating effective mental health treatments.
Purpose of the Study:
- Introduce the concept of clinical efficiency, linking resource expenditure to clinical outcomes.
- Present the incremental time efficiency ratio (ITER) as a novel metric for evaluating interventions.
- Advocate for the use of clinical efficiency metrics to inform healthcare decisions and improve treatment delivery.
Main Methods:
- Define clinical efficiency as a framework connecting resource use with therapeutic gains.
- Introduce the incremental time efficiency ratio (ITER) for quantifying intervention benefits.
- Discuss the applicability of cost-effectiveness analysis and related strategies to clinical efficiency.
Main Results:
- The ITER metric can quantify the benefits of various intervention types, including low-intensity, concentrated, and stepped-care approaches.
- ITER can be estimated for both past and future clinical trials, providing valuable data for researchers.
- Focusing on clinical efficiency and metrics like ITER can enhance communication of treatment benefits.
Conclusions:
- Clinical efficiency, particularly measured by ITER, provides essential data for healthcare gatekeepers to make informed referral decisions.
- Adoption of clinical efficiency metrics can facilitate the widespread dissemination of evidence-based mental health care.
- Increased focus on resource utilization and outcomes can improve the delivery of high-quality mental health services to more patients.
Related Concept Videos
01:28Antimicrobial Effectiveness
646
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
646
01:22Dose-Response Relationship: Potency and Efficacy
5.7K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.7K
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
28
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
28
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
207
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207
01:16Bioequivalence Data: Statistical Interpretation
26
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
26
01:20Measurement of Bioavailability: Pharmacodynamic Methods
34
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
34